Next Article in Journal
Virtual Reality Training for Balance in Patients with Chronic Low Back Pain: A Systematic Review and Meta-Analysis
Previous Article in Journal
Comparison of Non-Surgical Methods for Implant Surface Treatment in Simulated Bone Resorption Patterns: An In Vitro Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Antibody Secretion Capacity in CVID Patients: Immunoglobulin Isotypes and Antigen Specificities After T-Cell-Dependent In Vitro Stimulation †

1
Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
2
Center for Regenerative Therapies (BCRT), Berlin Institute of Health (BIH), Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
*
Author to whom correspondence should be addressed.
This article is Parts of the poster presentation entitled “The in vitro functional memory B cell response is intact in most patients with Common Variable Immunodeficiency Disorder”. Presented as poster at the 7th European Congress of Immunology (ECI), Dublin, Ireland, 1–4 September 2024.
J. Clin. Med. 2025, 14(20), 7246; https://doi.org/10.3390/jcm14207246 (registering DOI)
Submission received: 26 August 2025 / Revised: 19 September 2025 / Accepted: 30 September 2025 / Published: 14 October 2025
(This article belongs to the Section Immunology & Rheumatology)

Abstract

Background: Common variable immunodeficiency (CVID), the most prevalent symptomatic inborn error of immunity, involves impaired B-cell differentiation and antibody production, causing recurrent infections and the need for life-long immunoglobulin replacement therapy. Methods: This study evaluated the in vitro differentiation of memory B-cells (MBCs) into antibody-secreting cells (ASCs) in CVID patients. Peripheral blood mononuclear cells from 13 CVID patients and 10 healthy controls were stimulated using two protocols: (I) Staphylococcus aureus Cowan Strain I, Pokeweed mitogen, and CpG, or (II) a T-cell-dependent approach using CD40 ligand, interleukin-21, and CpG. B-cell subpopulations were analyzed by flow cytometry, ASC differentiation using ELISpot, and antibody levels in supernatants by ELISA. Results: Despite severely restricted in vivo antibody production, MBCs from all 13 CVID patients differentiated into IgG and IgM ASCs under adequate in vitro stimulation. Protocol II, mimicking T-cell help, was more effective than protocol I. As expected, the patients exhibited reduced class-switched MBCs ex vivo, but the MBCs differentiated and proliferated to an extent similar to those in healthy controls. IgA secretion remained significantly impaired post-stimulation. Specific IgG antibodies against tetanus toxoid and Streptococcus pneumoniae were detected in the patient supernatants, while no double-stranded DNA autoantibodies emerged after in vitro stimulation. Conclusions: These findings indicate that the MBCs of most patients retain functional B-cell differentiation and antigen-specific IgG secretion under T-cell dependent stimulation, though IgA secretion remains impaired. Tailored stimulation protocols could deepen our understanding of how to restore MBC formation in CVID patients in vivo. This methodology provides a platform to investigate antigen-specific functional memory responses like post-vaccination.
Keywords: common variable immunodeficiency disorder (CVID); inborn error of immunity (IEI); antibody-secreting cells (ASCs); memory B-cell differentiation; ELISpot common variable immunodeficiency disorder (CVID); inborn error of immunity (IEI); antibody-secreting cells (ASCs); memory B-cell differentiation; ELISpot

Share and Cite

MDPI and ACS Style

Steiner, S.; Wittke, K.; Bauer, S.; Scheibenbogen, C.; Hanitsch, L.G. Antibody Secretion Capacity in CVID Patients: Immunoglobulin Isotypes and Antigen Specificities After T-Cell-Dependent In Vitro Stimulation. J. Clin. Med. 2025, 14, 7246. https://doi.org/10.3390/jcm14207246

AMA Style

Steiner S, Wittke K, Bauer S, Scheibenbogen C, Hanitsch LG. Antibody Secretion Capacity in CVID Patients: Immunoglobulin Isotypes and Antigen Specificities After T-Cell-Dependent In Vitro Stimulation. Journal of Clinical Medicine. 2025; 14(20):7246. https://doi.org/10.3390/jcm14207246

Chicago/Turabian Style

Steiner, Sophie, Kirsten Wittke, Sandra Bauer, Carmen Scheibenbogen, and Leif G. Hanitsch. 2025. "Antibody Secretion Capacity in CVID Patients: Immunoglobulin Isotypes and Antigen Specificities After T-Cell-Dependent In Vitro Stimulation" Journal of Clinical Medicine 14, no. 20: 7246. https://doi.org/10.3390/jcm14207246

APA Style

Steiner, S., Wittke, K., Bauer, S., Scheibenbogen, C., & Hanitsch, L. G. (2025). Antibody Secretion Capacity in CVID Patients: Immunoglobulin Isotypes and Antigen Specificities After T-Cell-Dependent In Vitro Stimulation. Journal of Clinical Medicine, 14(20), 7246. https://doi.org/10.3390/jcm14207246

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop